These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 16608895)

  • 1. Gonadoblastoma arising in undifferentiated gonadal tissue within dysgenetic gonads.
    Cools M; Stoop H; Kersemaekers AM; Drop SL; Wolffenbuttel KP; Bourguignon JP; Slowikowska-Hilczer J; Kula K; Faradz SM; Oosterhuis JW; Looijenga LH
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2404-13. PubMed ID: 16608895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Undifferentiated gonadal tissue, Y chromosome instability, and tumors in XY gonadal dysgenesis.
    Beaulieu Bergeron M; Lemieux N; Brochu P
    Pediatr Dev Pathol; 2011; 14(6):445-59. PubMed ID: 21692598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of germ cells at risk for neoplastic transformation in gonadoblastoma: an immunohistochemical study for OCT3/4 and TSPY.
    Kersemaekers AM; Honecker F; Stoop H; Cools M; Molier M; Wolffenbuttel K; Bokemeyer C; Li Y; Lau YF; Oosterhuis JW; Looijenga LH
    Hum Pathol; 2005 May; 36(5):512-21. PubMed ID: 15948118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Classical gonadoblastoma: its relationship to the 'dissecting' variant and undifferentiated gonadal tissue.
    Roth LM; Cheng L
    Histopathology; 2018 Mar; 72(4):545-555. PubMed ID: 28881049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneity of gonadoblastoma germ cells: similarities with immature germ cells, spermatogonia and testicular carcinoma in situ cells.
    Jørgensen N; Müller J; Jaubert F; Clausen OP; Skakkebaek NE
    Histopathology; 1997 Feb; 30(2):177-86. PubMed ID: 9190360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neoplastic potential of germ cells in relation to disturbances of gonadal organogenesis and changes in karyotype.
    Słowikowska-Hilczer J; Romer TE; Kula K
    J Androl; 2003; 24(2):270-8. PubMed ID: 12634315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovarian dysgerminomas are characterised by frequent KIT mutations and abundant expression of pluripotency markers.
    Hoei-Hansen CE; Kraggerud SM; Abeler VM; Kaern J; Rajpert-De Meyts E; Lothe RA
    Mol Cancer; 2007 Feb; 6():12. PubMed ID: 17274819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The risk of neoplasm associated with dysgenetic testes in prepubertal and pubertal/adult patients.
    Slowikowska-Hilczer J; Szarras-Czapnik M; Wolski JK; Oszukowska E; Hilczer M; Jakubowski L; Walczak-Jedrzejowska R; Marchlewska K; Filipiak E; Kaluzewski B; Baka-Ostrowska M; Niedzielski J; Kula K
    Folia Histochem Cytobiol; 2015; 53(3):218-26. PubMed ID: 26314751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor risk in disorders of sex development (DSD).
    Looijenga LH; Hersmus R; Oosterhuis JW; Cools M; Drop SL; Wolffenbuttel KP
    Best Pract Res Clin Endocrinol Metab; 2007 Sep; 21(3):480-95. PubMed ID: 17875493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of the Y-containing cell line on histological differentiation patterns in dysgenetic gonads.
    Cools M; Boter M; van Gurp R; Stoop H; Poddighe P; Lau YF; Drop SL; Wolffenbuttel KP; Looijenga LH
    Clin Endocrinol (Oxf); 2007 Aug; 67(2):184-92. PubMed ID: 17547684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gonadoblastoma: evidence for a stepwise progression to dysgerminoma in a dysgenetic ovary.
    Pauls K; Franke FE; Büttner R; Zhou H
    Virchows Arch; 2005 Sep; 447(3):603-9. PubMed ID: 15968543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gonadoblastoma Y locus genes expressed in germ cells of individuals with dysgenetic gonads and a Y chromosome in their karyotypes include DDX3Y and TSPY.
    Vogt PH; Besikoglu B; Bettendorf M; Frank-Herrmann P; Zimmer J; Bender U; Knauer-Fischer S; Choukair D; Sinn P; Lau YC; Heidemann PH; Strowitzki T
    Hum Reprod; 2019 Apr; 34(4):770-779. PubMed ID: 30753444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FOXL2 and SOX9 distinguish the lineage of the sex cord-stromal cells in gonadoblastomas.
    Buell-Gutbrod R; Ivanovic M; Montag A; Lengyel E; Fadare O; Gwin K
    Pediatr Dev Pathol; 2011; 14(5):391-5. PubMed ID: 21682576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gonadoblastoma: origin and outcome.
    Roth LM; Cheng L
    Hum Pathol; 2020 Jun; 100():47-53. PubMed ID: 31805291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is a CIS phenotype apparent in children with Disorders of Sex Development? Milder testicular dysgenesis is associated with a higher risk of malignancy.
    Chemes HE; Venara M; Del Rey G; Arcari AJ; Musse MP; Papazian R; Forclaz V; Gottlieb S
    Andrology; 2015 Jan; 3(1):59-69. PubMed ID: 25598272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testis-specific protein Y-encoded gene is expressed in early and late stages of gonadoblastoma and testicular carcinoma in situ.
    Li Y; Vilain E; Conte F; Rajpert-De Meyts E; Lau YF
    Urol Oncol; 2007; 25(2):141-6. PubMed ID: 17349529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.
    Ulbright TM
    Mod Pathol; 2005 Feb; 18 Suppl 2():S61-79. PubMed ID: 15761467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bilateral gonadoblastomas in a dog with mixed gonadal dysgenesis.
    Reis-Filho JS; Ricardo S; Gärtner F; Schmitt FC
    J Comp Pathol; 2004; 130(2-3):229-33. PubMed ID: 15003485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of c-KIT mutations in gonadoblastoma and dysgerminomas of patients with disorders of sex development (DSD) and ovarian dysgerminomas.
    Hersmus R; Stoop H; van de Geijn GJ; Eini R; Biermann K; Oosterhuis JW; Dhooge C; Schneider DT; Meijssen IC; Dinjens WN; Dubbink HJ; Drop SL; Looijenga LH
    PLoS One; 2012; 7(8):e43952. PubMed ID: 22937135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of OCT3/4, TSPY and β-catenin as biological markers for gonadoblastoma formation and malignant germ cell tumor development in dysgenetic gonads.
    Palma I; Garibay N; Pena-Yolanda R; Contreras A; Raya A; Dominguez C; Romero M; Aristi G; Queipo G
    Dis Markers; 2013; 34(6):419-24. PubMed ID: 23396295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.